Skip to main content
. Author manuscript; available in PMC: 2012 Sep 9.
Published in final edited form as: Naunyn Schmiedebergs Arch Pharmacol. 1993 May;347(5):521–526. doi: 10.1007/BF00166745

Fig. 4.

Fig. 4

Sustained coronary vasodilation produced by APEC infused at a rate giving a concentration of 0.7 nM. Note that coronary flow (CBF) is stable throughout the entire period of agonist administration (solid bar), which lasted for 2 h and 45 min. This experiment is typical of two such experiments. The closed circle (●) represents control flow rate